Issue
PFAS clinical guidance, testing, and medical monitoring
Decide whether federal agencies should commission recurring health reviews, issue public clinical guidance with community input, cover doctor-ordered PFAS blood tests through Medicare, and support medical monitoring after serious exposure.
Bills connected to this issue